Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00821288 · ClinicalTrials.gov registry record · NA

Post-treatment Care of Breast Cancer Survivors

A NA study of Breast Neoplasm, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT00821288 is a NA study of Breast Neoplasm that has completed, run by Columbia University. The registered enrollment target is 140 participants, below the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00821288, a NA study of Breast Neoplasm, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this proposal is to improve the post-treatment care of breast cancer survivors and to understand the barriers to optimal post-treatment care in Latina and Non-Hispanic women.

Conditions Studied

Interventions

  • BEHAVIORAL Survivorship Intervention
  • BEHAVIORAL Facing Forward

Study Locations (1)

New York

  • Columbia Unviersity Medical Center - New York

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2007-07
Est. Completion 2013-05
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT00821288

The ClinicalTrials.gov registry entry for NCT00821288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (11% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Survivorship Intervention is the first listed.

NCT00821288 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00821288 about?

NCT00821288 is a clinical study titled "Post-treatment Care of Breast Cancer Survivors". The overall goal of this proposal is to improve the post-treatment care of breast cancer survivors and to understand the barriers to optimal post-treatment care in Latina and Non-Hispanic women.

What is the current status of trial NCT00821288?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2007-07. Estimated completion is 2013-05.

What conditions does trial NCT00821288 study?

This clinical trial studies the following conditions: Breast Neoplasm.

What interventions are being tested in trial NCT00821288?

The interventions under investigation include: Survivorship Intervention (BEHAVIORAL), Facing Forward (BEHAVIORAL).

Who is sponsoring clinical trial NCT00821288?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00821288 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.